Peptide science, dosage protocols, and research findings.
BPC-157 and TB-500 target tissue repair through complementary mechanisms. Here's what the research shows about combining them, and why the pairing has become a staple in recovery-focused peptide research.
Retatrutide activates GLP-1, GIP, and glucagon receptors simultaneously. Here's what the Phase 2 trial data shows and why researchers are paying close attention.
A deep dive into GHK-Cu — how this naturally occurring copper peptide resets gene expression, drives collagen synthesis, and what the peer-reviewed literature actually shows.
BPC-157 (Body Protection Compound 157) is one of the most studied peptides in preclinical research. Here's what the literature says about its mechanisms, applications, and protocols.
